(90 days)
Not Found
No
The document explicitly states "Mentions AI, DNN, or ML: Not Found" and describes the device as using "proprietary DSP circuitry and software" and "thoracic electrical bioimpedance (TEB)" for parameter measurement, without mentioning any AI/ML components.
No.
The device is intended to monitor hemodynamic parameters, not to treat a condition.
Yes
The device is intended to "monitor a patient's hemodynamic parameters," which are clinical measurements used to assess the physiological state and health of a patient, thereby aiding in diagnosis and management. The collection and display of these parameters serve a diagnostic purpose.
No
The device description explicitly lists hardware components including an Instrument (containing DSP and Patient Interface Circuitry, Intel 80X86 Processor Board, DSP firmware and user software, power supply, built-in flat-panel screen, keyboard/keypad, power cord), Patient Cable, and Electrodes/Transducers. It also describes using thoracic electrical bioimpedance (TEB) by attaching electrodes to the patient and injecting a current, which requires hardware.
Based on the provided information, the BioZ.com Hemodynamic Monitor is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In Vitro Diagnostics are tests performed on samples taken from the human body, such as blood, urine, or tissue, to detect diseases, conditions, or infections.
- BioZ.com Function: The BioZ.com Hemodynamic Monitor uses thoracic electrical bioimpedance (TEB) by attaching electrodes to the patient's skin (neck and thorax) and injecting a minimal current to measure hemodynamic parameters. This is a non-invasive, in-vivo measurement technique performed directly on the patient's body, not on a sample taken from the body.
- Intended Use: The intended use is to "monitor a patient's hemodynamic parameters," which are physiological measurements taken from the living patient.
Therefore, the BioZ.com Hemodynamic Monitor falls under the category of in-vivo diagnostic or monitoring devices, not in-vitro diagnostics.
N/A
Intended Use / Indications for Use
The BioZ.com Hemodynamic Monitor is intended to monitor a patient's hemodynamic parameters. These parameters include:
ECG
Heart Rate
Pre-ejection Period
Left Ventricular Ejection Time
Systolic Time Ratio
Stroke Volume
Cardiac Output
Cardiac Index
Systemic Vascular Resistance
End Diastolic Volume
End Diastolic Index
Index of Contractility
Acceleration Index
Left Cardiac Work
Thoracic Fluid Content
Respiration Rate
Product codes
74 DSB
Device Description
The BioZ.com System is a self-contained computer-based product utilizing CardioDynamics proprietary DSP circuitry and software. Each system consists of the following components:
- Instrument:
- A. CardioDynamics proprietary DSP and Patient Interface Circuitry
- B. Intel 80X86 Processor Board
- C. CardioDynamics proprietary DSP firmware and user software
- D. Condor Medical grade power supply
- E. Built in flat-panel screen
- F. Keyboard/keypad
- G. Power Cord
- Patient Cable
- Electrodes/Transducers
The BioZ.com is a CDIc-proprietary platform with built-in keypad and screen (a QWERTY keyboard is an optional accessory). The BioZ.com can operate from AC power or from an internal rechargeable battery for limited patient transport use. The CardioDynamics proprietary DSP circuitry used in the BioZ.com has partitioning changes to the boards to accommodate the plastic enclosure and different Intel 80X86 family processor chip. The BioZ.com also provides a user-selectable option of a secondary equation for the calculation of the Stroke Volume parameter (Bernstein) in addition to the single Sramek-Bernstein equation.
Screen differences were required to accommodate the 320 x 240 dot display of the BioZ.com. The BioZ.com System will offer only the Patient Data Entry, Monitoring, Therapeutic, Diagnostic and Trending Screens. User configuration of the Monitoring, Diagnostic, and Trending screen in the BioZ.com makes additional screens unnecessary. The BioZ.com System will display up to 5 parameters at a time. The BioZ.com System Monitoring, Diagnostic and Trending Screens can be configured to display a set number of parameters including ECG, Heart Rate, Pre-ejection Period, Left Ventricular Ejection Time, Systolic Time Ratio, Stroke Volume, Cardiac Output, Cardiac Index, End Diastolic Volume, Systemic Vascular Resistance, Left Cardiac Work, Systemic Vascular Resistance indexed, End Diastolic Index, Index of Contractility, Acceleration Index, Left Cardiac Work Index, Thoracic Fluid Content, and Respiration Rate. The Monitoring Screen in the BioZ.com can be configured to display any two of the following waveforms: Impedance, ECG, ΔZ, dZ/dT, Pacer Impulse, Spike Enhanced ECG and/or no waveform. The Waveform Screen is new to the BioZ.com and will show the five parameters selected by the user for the Monitoring Screen along with larger and longer displays of two of the waveforms available in the Monitoring Screen. In the BioZ.com System software, there are a number of default values such as CVP, PAOP, height and weight units, automatic data save timing, etc., which the user will be able to change.
The BioZ.com System will be able to receive and transmit data to many common hospital monitoring systems, using their established, documented protocols.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
thoracic electrical bioimpedance
Indicated Patient Age Range
Not Found
Intended User / Care Setting
hospital, outpatient and clinical settings
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Digitized waveforms from a number of patients with various clinical conditions were input into the BioZ Portable System and then the BioZ.com System. After one minute, three parameters were recorded for each device.
Summary of Performance Studies
Accuracy and Equivalency Test was performed comparing the CardioDynamics BioZ.com System to the CardioDynamics BioZ Portable. The purpose of the protocol was to demonstrate that the BioZ.com System is substantially equivalent to the CardioDynamics BioZ Portable System. Digitized waveforms from a number of patients with various clinical conditions were input into the BioZ Portable System and then the BioZ.com System. After one minute, three parameters were recorded for each device. The measurement and calculations performed by the device achieved the expected results.
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 870.2770 Impedance plethysmograph.
(a)
Identification. An impedance plethysmograph is a device used to estimate peripheral blood flow by measuring electrical impedance changes in a region of the body such as the arms and legs.(b)
Classification. Class II (special controls). The device, when it is a body composition analyzer which is not intended to diagnose or treat any medical condition, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 870.9.
0
MAR | 8 1998
SECTION 2 -- SUMMARY AND CERTIFICATION
A. 510(K) SUMMARY
SUBSTANTIAL EQUIVALENCE:
Identification of predicate device, model and manufacturer:
Predicate device: CardioDynamics BioZ Portable System
BZ - 125 Model:
ﻣﺤﻤﺴﺴﺴ
Manufacturer: CardioDynamics International, Corp.
Predicate device 510(k) # K972320
Reason For Submission: Device Modification -- Repackaging
The BioZ.com System is substantially equivalent to its predicate device, the CardioDynamics BioZ Portable System currently being marketed by CardioDynamics International Corp. The justification for this substantial equivalence determination is presented below.
The BioZ.com System is substantially equivalent to the CardioDynamics BioZ Portable System in terms of design. intended use and principals of operation. Both systems are portable in design and for use in the hospital, outpatient and clinical settings. The intended use of each systems is to noninvasively measure a patients hemodynamic parameters using thoracic electrical bioimpedance (TEB). Monitoring is accomplished by attaching 8 electrodes to the patient (two on each side of the neck and thorax) and injecting a minimal current through the upper electrodes and reading the returning voltage waveform from the inner electrodes.
Since both systems use the same CardioDynamics proprietary DSP circuitry and software, the formulas and algorithms used to calculate the various hemodynamic parameters are essentially the same. In addition, all required input parameters are the same, including patient gender, body frame size, height, weight, age and blood pressure.
The BioZ Portable System and the BioZ.com System are self-contained computer-based products utilizing the same CardioDynamics proprietary DSP circuitry and software. Each system consists of the following components:
- Instrument:
- A. CardioDynamics proprietary DSP and Patient Interface Circuitry
- B. Intel 80X86 Processor Board
- C. CardioDynamics proprietary DSP firmware and user software
- D. Condor Medical grade power supply
- E. Built in flat-panel screen
- F. Keyboard/keypad
- G. Power Cord
-
- Patient Cable
-
- Electrodes/Transducers
1
The key differences between the two devices are that the CardioDynamics BioZ Portable is based on an off-the-shelf (Dolch brand) PC based system utilizing a full QWERTY keyboard, while the BioZ.com is a CDIc-proprietary platform with built-in keypad and screen (a QWERTY keyboard is an optional accessory). In addition, the BioZ Portable operates exclusively on AC power while the BioZ.com can operate from AC power or from an internal rechargeable battery for limited patient transport use. Although the CardioDynamics proprietary DSP circuitry used in both devices is the same, partitioning changes were made to the boards used in the BioZ com to accommodate the plastic enclosure and different Intel 80X86 family processor chip. The BioZ.com also provides a user-selectable option of a secondary equation for the calculation of the Stroke Volume parameter (Bernstein) in addition to the single Sramek-Bernstein equation in the BioZ portable.
Screen differences were required to accommodate the 320 x 240 dot display of the BioZ.com rather than the 640 x 480 dot display in the BioZ Portable. Screen differences between the BioZ Portable and the BioZ.com include:
- While the BioZ System offered the Patient Data Entry, Monitoring, Indexed Data, 1. Therapeutic, Indexed Therapeutic, Diagnostic, Interactive Trending and Trending Screens, the BioZ.com System will offer only the Patient Data Entry, Monitoring, Therapeutic, Diagnostic and Trending Screens. User configuration of the Monitoring, Diagnostic, and Trending screen in the BioZ.com makes the additional screens unnecessary.
- On many of the BioZ Portable Screens, 7 to 10 parameters were shown at any given 2. time. The BioZ.com System will display up to 5 parameters at a time.
- The parameters shown on the individual BioZ Portable screens were pre-set and could 3. not be changed. The BioZ.com System Monitoring, Diagnostic and Trending Screens can be configured to display a set number of the following parameters:
| ECG | Heart Rate |
|---|---|
| Pre-ejection Period | Left Ventricular Ejection Time |
| Systolic Time Ratio | Stroke Volume |
| Cardiac Output | Cardiac Index |
| End Diastolic Volume | Systemic Vascular Resistance |
| Left Cardiac Work | Systemic Vascular Resistance indexed |
| End Diastolic Index | Index of Contractility |
| Acceleration Index | Left Cardiac Work Index |
| Thoracic Fluid Content | Respiration Rate |
-
- The Monitoring Screen in the BioZ.com can be configured to display any two of the following waveforms: Impedance, ECG, ΔZ, dZ/dT, Pacer Impulse, Spike Enhanced ECG and/or no waveform. The BioZ Portable always showed ECG, with a user option for a second waveform of either ΔZ or dZ/dT.
2
- The Waveform Screen is new to the BioZ.com. The screen will show the five 6. parameters selected by the user for the Monitoring Screen along with larger and longer displays of two of the waveforms available in the Monitoring Screen.
-
- In the BioZ.com System software, there are a number of default values such as CVP, PAOP, height and weight units, automatic data save timing, etc. The user will be able to change the default values within the BioZ.com Software. The BioZ Portable had limited user control over default values.
Another difference between the BioZ Portable and the BioZ.com System is that the BioZ Portable was able to receive external data from two blood pressure devices and one pulse oximeter. The BioZ.com System will be able to receive and transmit data to many common hospital monitoring systems, using their established, documented protocols.
To demonstrate that the two systems are functionally equivalent, an Accuracy and Equivalency Test was performed comparing the CardioDynamics BioZ.com System to the CardioDynamics BioZ Portable The purpose of the protocol was to demonstrate that the BioZ.com System is substantially equivalent to the CardioDynamics BioZ Portable System. Digitized waveforms from a number of patients with various clinical conditions were input into the BioZ Portable System and then the BioZ.com System. After one minute, three parameters were recorded for each device. The measurement and calculations performed by the device achieved the expected results.
3
Image /page/3/Picture/1 description: The image is a black and white seal for the Department of Health & Human Services USA. The seal is circular with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. In the center of the seal is a stylized image of an eagle with its wings spread.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
MAR 18 1998
Mr. Dennis G. Hepp Chief Technology Officer CardioDynamics International Corp. 6175 Nancy Ridge Drive, Suite 300 San Diego, CA 92121
- K974725 Re: BIOZ.COM SYSTEM II (two) Requlatory Class: Product Code: 74 DSB December 18, 1997 Dated: December 23, 1997 Received:
Dear Mr. Hepp:
We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Druq, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labelinq, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major requlations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.
4
This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial in your of your device to a legally marketed predicate device equits in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at (301) 594-4648. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR 807.97). Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its internet address "http://www.fda.gov/cdrh/dsmamain.html".
Sincerely yours,
Thomas J. Callahon
Thomas J. Callahan, Ph. D. Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
5
510(k) Number (if known):
Device Name: BioZ.com Hemodynamic Monitor
Indications for Use:
The BioZ.com Hemodynamic Monitor is intended to monitor a patient's hemodynamic parameters. These parameters include:
| ECG | Heart Rate |
|---|---|
| Pre-ejection Period | Left Ventricular Ejection Time |
| Systolic Time Ratio | Stroke Volume |
| Cardiac Output | Cardiac Index |
| Systemic Vascular Resistance | End Diastolic Volume |
| End Diastolic Index | Index of Contractility |
| Acceleration Index | Left Cardiac Work |
| Thoracic Fluid Content | Respiration Rate |
(PLEASE DO NOT WRITE BELOW THIS LINE. CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
| (Division Sign-Off) | |
|---|---|
| Division of Cardiovascular, Respiratory, and Neurological Devices | |
| 510(k) Number |
| Prescription Use | ✓ | OR | Over-The-Counter Use | |
|---|---|---|---|---|
| (PER 21 CFR 801.109) |
(Optional Format 1-2-96)